(Q43128336)

14 November 2017

Posaconazole therapeutic drug monitoring: a reference laboratory experience (English)

1 reference

14 November 2017

5

Thomas F Patterson

1 reference

14 November 2017

3

Gennethel Pennick

1 reference

14 November 2017

2

Michael G Rinaldi

1 reference

14 November 2017

George R Thompson

1

1 reference

14 November 2017

Sheryl A Dorsey

series ordinal

4

1 reference

14 November 2017

James S Lewis

series ordinal

6

1 reference

14 November 2017

language of work or name

English

0 references

publication date

2 March 2009

1 reference

Antimicrobial Agents and Chemotherapy

14 November 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 November 2017

53

1 reference

14 November 2017

5

1 reference

14 November 2017

2223-2224

1 reference

Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681542

Antifungal therapeutic drug monitoring: established and emerging indications

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681542

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681542

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681542

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681542

Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681542

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681542

Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681542

15 August 2018

Identifiers

DOI

10.1128/AAC.00240-09

1 reference

14 November 2017

1 reference

14 November 2017

PubMed publication ID

19258264

1 reference